Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
Titel:
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
Auteur:
Yacoub, Abdulraheem Borate, Uma Rampal, Raajit K. Ali, Haris Wang, Eunice S. Gerds, Aaron T. Hobbs, Gabriela Kremyanskaya, Marina Winton, Elliott O’Connell, Casey Goel, Swati Oh, Stephen T. Schiller, Gary McCloskey, James Palmer, Jeanne Holmes, Houston Hager, Steven Assad, Albert Erickson-Viitanen, Susan Zhou, Feng Daver, Naval